Sona Jain

Dr. Sona Jain

Programa de Pós-Graduação em Biotecnologia Industrial, Universidade Tiradentes, Aracaju, Sergipe
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2019 in Microbial Drug Resistance
Verified
Journal Article
Closed access
RVRoberto Vivas
Roberto Vivas
ABAna Andréa Teixeira Barbosa
Ana Andréa Teixeira Barbosa
SDSilvio Dolabella
Silvio Dolabella
SJSona Jain
Sona Jain
Antibiotic resistance is one of the greatest challenges in the health system nowadays, representing a serious problem for public health. Initially, antibiotic-resistant strains were restricted to the hospital environment, but now they can be found everywhere. Globalization, excessive use of antibiotics in animal husbandry and aquaculture, use of multiple broad-spectrum agents, and lack of good antimicrobial stewardship can be listed as the factors most responsible for the spread of antibiotic resistance. The increase in the prevalence of antibiotic-resistant pathogens implies having fewer antimicrobial agents to treat infections. The estimate is that by 2050, there will be no effective antibiotic available, if no new drug is developed or discovered. This raises the need to search for alternative methods of controlling antibiotic-resistant pathogens. Considering this problem, the objective of this review is to outline the most frequent antibiotic-resistant bacteria and describe the advantageous and limitations of alternative methods that have been proposed to control them.

13 August 2021 in Bioengineering
Verified
Journal Article
Open access
PDF file
TBThiago Rodrigues Bjerk
Thiago Rodrigues Bjerk
Patricia SeverinoPatricia Severino
Patricia Severino
SJSona Jain
Sona Jain
CMConrado Marques
Conrado Marques
ASAmelia Silva
Amelia Silva
Eliana B. SoutoEliana B. Souto
Eliana B. Souto
Surfactants are amphiphilic compounds having hydrophilic and hydrophobic moieties in their structure. They can be of synthetic or of microbial origin, obtained respectively from chemical synthesis or from microorganisms’ activity. A new generation of ecofriendly surfactant molecules or biobased surfactants is increasingly growing, attributed to their versatility of applications. Surfactants can be used as drug delivery systems for a range of molecules given their capacity to create micelles which can promote the encapsulation of bioactives of pharmaceutical interest; besides, these assemblies can also show antimicrobial properties. The advantages of biosurfactants include their high biodegradability profile, low risk of toxicity, production from renewable sources, functionality under extreme pH and temperature conditions, and long-term physicochemical stability. The application potential of these types of polymers is related to their properties enabling them to be processed by emulsification, separation, solubilization, surface (interfacial) tension, and adsorption for the production of a range of drug delivery systems. Biosurfactants have been employed as a drug delivery system to improve the bioavailability of a good number of drugs that exhibit low aqueous solubility. The great potential of these molecules is related to their auto assembly and emulsification capacity. Biosurfactants produced from bacteria are of particular interest due to their antibacterial, antifungal, and antiviral properties with therapeutic and biomedical potential. In this review, we discuss recent advances and perspectives of biosurfactants with antimicrobial properties and how they can be used as structures to develop semisolid hydrogels for drug delivery, in environmental bioremediation, in biotechnology for the reduction of production costs and also their ecotoxicological impact as pesticide alternative.

3 January 2017 in Critical Reviews in Biotechnology
Verified
Journal Article
Closed access
ABAna Andréa Teixeira Barbosa
Ana Andréa Teixeira Barbosa
HMHilario Mantovani
Hilario Mantovani
SJSona Jain
Sona Jain
Bacteriocins produced by lactic acid bacteria (LAB) are well-recognized for their potential as natural food preservatives. These antimicrobial peptides usually do not change the sensorial properties of food products and can be used in combination with traditional preservation methods to ensure microbial stability. In recent years, fruit products are increasingly being associated with food-borne pathogens and spoilage microorganisms, and bacteriocins are important candidates to preserve these products. Bacteriocins have been extensively studied to preserve foods of animal origin. However, little information is available for their use in vegetable products, especially in minimally processed ready-to-eat fruits. Although, many bacteriocins possess useful characteristics that can be used to preserve fruit products, to date, only nisin, enterocin AS-48, bovicin HC5, enterocin 416K1, pediocin and bificin C6165 have been tested for their activity against spoilage and pathogenic microorganisms in these products. Among these, only nisin and pediocin are approved to be commercially used as food additives, and their use in fruit products is still limited to certain countries. Considering the increasing demand for fresh-tasting fruit products and concern for public safety, the study of other bacteriocins with biochemical characteristics that make them candidates for the preservation of these products are of great interest. Efforts for their approval as food additives are also important. In this review, we discuss why the study of bacteriocins as an alternative method to preserve fruit products is important; we detail the biotechnological approaches for the use of bacteriocins in fruit products; and describe some bacteriocins that have been tested and have potential to be tested for the preservation of fruit products.

1 September 2002 in Current Genetics
Verified
Journal Article
Closed access
PDF file
SJSona Jain
Sona Jain
KAKouichi Akiyama
Kouichi Akiyama
KMKenjiro Mae
Kenjiro Mae
TOTomizo Ohguchi
Tomizo Ohguchi
RTRenkichi Takata
Renkichi Takata

29 August 2022 in Biomolecules
Verified
Journal Article
Open access
PDF file
Iwona CichaIwona Cicha
Iwona Cicha
Ronny PrieferRonny Priefer
Ronny Priefer
Patricia SeverinoPatricia Severino
Patricia Severino
Eliana B. SoutoEliana B. Souto
Eliana B. Souto
SJSona Jain
Sona Jain
Biosensor-integrated drug delivery systems are innovative devices in the health area, enabling continuous monitoring and drug administration. The use of smart polymer, bioMEMS, and electrochemical sensors have been extensively studied for these systems, especially for chronic diseases such as diabetes mellitus, cancer and cardiovascular diseases as well as advances in regenerative medicine. Basically, the technology involves sensors designed for the continuous analysis of biological molecules followed by drug release in response to specific signals. The advantages include high sensitivity and fast drug release. In this work, the main advances of biosensor-integrated drug delivery systems as new biomedical materials to improve the patients’ quality of life with chronic diseases are discussed.

8 February 2003 in Current Genetics
Verified
Journal Article
Closed access
SJSona Jain
Sona Jain
KAKouichi Akiyama
Kouichi Akiyama
TKTakuya Kan
Takuya Kan
TOTomizo Ohguchi
Tomizo Ohguchi
RTRenkichi Takata
Renkichi Takata